Isodiol International Competitors

Abacus Health Products (OTCMKTS:ABAHF) and Isodiol International (OTCMKTS:ISOLF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Earnings & Valuation

This table compares Abacus Health Products and Isodiol International's gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Abacus Health Products and Isodiol International, as reported by MarketBeat.com.

Profitability

This table compares Abacus Health Products and Isodiol International's net margins, return on equity and return on assets.

Isodiol International (OTCMKTS:ISOLF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Profitability

This table compares Isodiol International and Acreage's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings for Isodiol International and Acreage, as reported by MarketBeat.com.

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Isodiol International.

Earnings and Valuation

This table compares Isodiol International and Acreage's revenue, earnings per share and valuation.

Summary

Acreage beats Isodiol International on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Isodiol International (OTCMKTS:ISOLF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

This table compares Applied Biosciences and Isodiol International's revenue, earnings per share and valuation.

Profitability

This table compares Applied Biosciences and Isodiol International's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings for Applied Biosciences and Isodiol International, as provided by MarketBeat.

Isodiol International (OTCMKTS:ISOLF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Isodiol International and Ayr Strategies, as reported by MarketBeat.com.

Ayr Strategies has a consensus price target of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Isodiol International.

Profitability

This table compares Isodiol International and Ayr Strategies' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Isodiol International and Ayr Strategies' top-line revenue, earnings per share and valuation.

Summary

Ayr Strategies beats Isodiol International on 2 of the 2 factors compared between the two stocks.

Isodiol International (OTCMKTS:ISOLF) and Can B (NASDAQ:CANB) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Isodiol International and Can B, as reported by MarketBeat.

Earnings and Valuation

This table compares Isodiol International and Can B's revenue, earnings per share and valuation.

Profitability

This table compares Isodiol International and Can B's net margins, return on equity and return on assets.

Isodiol International (OTCMKTS:ISOLF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for Isodiol International and Cansortium, as provided by MarketBeat.

Cansortium has a consensus price target of $1.20, indicating a potential upside of 39.67%. Given Cansortium's higher probable upside, analysts clearly believe Cansortium is more favorable than Isodiol International.

Profitability

This table compares Isodiol International and Cansortium's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Isodiol International and Cansortium's gross revenue, earnings per share and valuation.

Summary

Cansortium beats Isodiol International on 2 of the 2 factors compared between the two stocks.